Now showing items 1-3 of 3
Deep Vein Thrombosis Following Non-Myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review
(Galenos Yayınevi, 2013)
The incidence of deep vein thrombosis (DVT) after non-myeloablative (NMA) allogeneic stem cell transplantation (allo-SCT) is unknown. In addition, very few studies on the predisposing factors for DVT post SCT have been ...
Transfection Of Myeloid Leukaemia Cell Lines Is Distinctively Regulated By Fibronectin Substratum
Gene transfer into haematopoietic cells is a challenging approach. The extracellular matrix component fibronectin has been known to modulate the cell cycle dynamics, viability and differentiation of leukaemia cells. Thus, ...
Long-Term Survival of Patients with Cll After Allogeneic Transplantation: A Report from the European Society for Blood and Marrow Transplantation
(Macmillan Publishers Limited, 2017)
Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-term survival ...